Filing Flows › Apyx Medical (APYX) › Q3 2025
Apyx Medical (APYX) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
Apyx Medical (APYX) reported revenue of $12.9M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +13% from the quarter before. Operating margin was -6.5%, net loss $2.0M (15.2% of revenue).
Apyx Medical, Q3 2025: revenue $12.9M (+12% year over year), operating margin -6.5%, net loss $2.0M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.9M | +13% | +12% |
| Operating profit | −$832K | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $12.9M in Q3 2025, up 12% year over year and up 13% from the previous quarter.
Gross margin was 64.4%, up 3.9 points from a year earlier. Operating costs exceeded revenue by $832K, an operating margin of -6.5%. Operating expenses fell 14% while revenue rose 12%. The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $3.7M loss. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was −$3.5M. Non-cash charges added back $164K of depreciation and amortization and $530K of share-based compensation. Working capital and other items used $2.3M. Capital expenditures of $519K exceeded it, leaving free cash flow of −$4.1M.
Questions
What was Apyx Medical's revenue in the third quarter 2025?
Apyx Medical (APYX) reported revenue of $12.9M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +13% from the quarter before.
Was Apyx Medical profitable in the third quarter 2025?
Operating loss was $832K (-6.5% of revenue) and net loss $2.0M.
Source: Apyx Medical 10-Q on SEC EDGAR.